Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
| Errataetall: |
CommentOn: J Infect. 2021 Apr;82(4):e29-e30. - PMID 33373652 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
The Journal of infection - 82(2021), 5 vom: 15. Mai, Seite e28-e30 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Borgonovo, Fabio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.04.2021 Date Revised 17.11.2021 published: Print-Electronic CommentOn: J Infect. 2021 Apr;82(4):e29-e30. - PMID 33373652 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.01.023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321057376 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321057376 | ||
| 003 | DE-627 | ||
| 005 | 20231225175013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.01.023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1070.xml |
| 035 | |a (DE-627)NLM321057376 | ||
| 035 | |a (NLM)33545166 | ||
| 035 | |a (PII)S0163-4453(21)00048-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Borgonovo, Fabio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.04.2021 | ||
| 500 | |a Date Revised 17.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2021 Apr;82(4):e29-e30. - PMID 33373652 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 700 | 1 | |a Passerini, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Piscaglia, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Morena, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Giacomelli, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Oreni, Letizia |e verfasserin |4 aut | |
| 700 | 1 | |a Dedivitiis, Gianfranco |e verfasserin |4 aut | |
| 700 | 1 | |a Lupo, Angelica |e verfasserin |4 aut | |
| 700 | 1 | |a Falvella, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Cossu, Maria Vittoria |e verfasserin |4 aut | |
| 700 | 1 | |a Capetti, Amedeo F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 82(2021), 5 vom: 15. Mai, Seite e28-e30 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2021 |g number:5 |g day:15 |g month:05 |g pages:e28-e30 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.01.023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 5 |b 15 |c 05 |h e28-e30 | ||